We are live on
!
Find out more
CC
CIBRA Capital Portfolio holdings
AUM
$207M
This Fund
S&P 500
This Quarter
Est. Return
+16%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$207M
AUM Growth
+$149M
(+256%)
Cap. Flow
+$141M
Cap. Flow
% of AUM
67.83%
Top 10 Holdings %
Top 10 Hldgs %
73.11%
Holding
37
New
19
Increased
5
Reduced
1
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SEE
Sealed Air
SEE
|
+$21.5M |
| 2 |
FOLD
Amicus Therapeutics
FOLD
|
+$21.2M |
| 3 |
TXNM
TXNM Energy Inc
TXNM
|
+$16.7M |
| 4 |
MASI
Masimo
MASI
|
+$14.2M |
| 5 |
AAUC
Allied Gold Corp
AAUC
|
+$12.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CFLT
Confluent
CFLT
|
+$5.49M |
| 2 |
Norfolk Southern
NSC
|
+$5.07M |
| 3 |
CYBR
CyberArk
CYBR
|
+$5.04M |
| 4 |
GTLS
Chart Industries
GTLS
|
+$4.74M |
| 5 |
CDTX
Cidara Therapeutics
CDTX
|
+$4.13M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 41.9% |
| 2 | Consumer Discretionary | 11.58% |
| 3 | Technology | 11.25% |
| 4 | Utilities | 9.33% |
| 5 | Materials | 7.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CDTX
26
DELISTED
Cidara Therapeutics
CDTX
| – | – |
-18,713
| Closed | -$4.13M |
|
|
CFLT
27
DELISTED
Confluent
CFLT
| – | – |
-181,500
| Closed | -$5.49M |
|
|
CYBR
28
DELISTED
CyberArk
CYBR
| – | – |
-11,291
| Closed | -$5.04M |
|
|
DENN
29
DELISTED
Denny's
DENN
| – | – |
-256,000
| Closed | -$1.59M |
|
|
EXAS
30
DELISTED
Exact Sciences
EXAS
| – | – |
-39,400
| Closed | -$4M |
|
|
FRGE
31
DELISTED
Forge Global Holdings
FRGE
| – | – |
-74,966
| Closed | -$3.34M |
|
|
GTLS
32
DELISTED
Chart Industries
GTLS
| – | – |
-22,986
| Closed | -$4.74M |
|
|
JAMF
33
DELISTED
Jamf
JAMF
| – | – |
-76,000
| Closed | -$989K |
|
|
JHG
34
DELISTED
Janus Henderson
JHG
| – | – |
-21,000
| Closed | -$999K |
|
35
Kenvue
KVUE
$36.6B
| – | – |
-124,000
| Closed | -$2.14M |
|
|
36
Norfolk Southern
NSC
$78.8B
| – | – |
-17,550
| Closed | -$5.07M |
|
|
RNAM
37
DELISTED
Avidity Biosciences
RNAM
| – | – |
-53,209
| Closed | -$3.84M |
|
Similar funds
TC
SNBOSD
BOJHT
SCM
OF
MFG
SIA
SPI
CIBRA Capital's Q1 2026 Portfolio in Review
As of Q1 2026, CIBRA Capital held 37 positions worth $207M, up 256% from $58.2M the previous quarter. Its ten largest holdings account for 73% of the portfolio.
CIBRA Capital deployed $141M of net new capital in Q1 2026, opening 19 new positions and adding to 5 existing holdings. Its largest new stake was Sealed Air: 514,636 shares worth $21.6M.
By sector, the portfolio is most concentrated in Healthcare at 42% of assets, up from 34% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Electronic Arts, an estimated $1.8M trimmed.
- CIBRA Capital's largest Q1 2026 buy was Sealed Air: 514,636 shares worth $21.6M.
- CIBRA Capital added most to Amicus Therapeutics in Q1 2026, an estimated $21.2M increase.
- CIBRA Capital's biggest Q1 2026 reduction was Electronic Arts, cutting an estimated $1.8M.
- CIBRA Capital fully exited Confluent in Q1 2026, selling an estimated $5.49M.
- CIBRA Capital's ten largest holdings make up 73% of its $207M portfolio in Q1 2026.
- CIBRA Capital opened 19 new positions and closed 12 in Q1 2026.
- CIBRA Capital's portfolio value rose 256% quarter-over-quarter to $207M.
Based on CIBRA Capital's 13F filing for Q1 2026, filed 24 Apr 2026.